Clearmind Advances CMND-100 Clinical Program with Third Cohort Enrollment in Phase I/IIa AUD Trial

Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and developm...

March 13, 2026 | Friday | News
Neuland Laboratories to Launch Commercial-Scale Peptide Manufacturing Facility in 2026

 Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 at its 17-acre Bonthapally manufacturing campus, with ...

March 11, 2026 | Wednesday | News
Lonza Group AG Selects Hyderabad for Global Capability Centre, Expanding Presence in India

Lonza Group AG, a world-leading contract development and manufacturing organisation (CDMO), has announced its decision to establish a new Global Capability...

March 09, 2026 | Monday | News
BioMed Realty Signs 15-Year Lease with CordenPharma Colorado for Purpose-Built Lab Facility at Flatiron Park

BioMed Realty, the largest private owner and operator of real estate for the life science, technology and innovation industries, announced that CordenPha...

March 06, 2026 | Friday | News
Codexis, Inc. Advances RNA Manufacturing with 50g siRNA Production Agreement for Cardiovascular Program

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing,  announced it has ent...

March 06, 2026 | Friday | News
Former BioDuro Leadership Launches Forma Life Sciences as Independent CDMO

-Forma Life Sciences, Inc. announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on o...

March 05, 2026 | Thursday | News
FUJIFILM Biotechnologies Launches ShunzymeX™ to Transform Microbial Downstream Processing

FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, &nb...

March 05, 2026 | Thursday | News
Quotient Sciences and Ipsen Expand Commercial Manufacturing Partnership to Secure Supply of Ultra-Rare FOP Therapy

Quotient Sciences, a leading integrated CRDMO (Contract Research, Development and Manufacturing Organization), is pleased to announce an extended commerc...

March 02, 2026 | Monday | News
Integrated Partnerships for Enabling Agility in Biologics Development

As biologic modalities grow more complex and timelines compress, the operational relationship between contract development and manufacturing organizations ...

March 02, 2026 | Monday | Opinion
SteinCares and Shilpa Biologicals Forge Strategic Biosimilar Partnership to Expand Access Across Latin America

New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization...

February 27, 2026 | Friday | News
Charles River Laboratories Raises 2026 Profit Forecast Following Strategic Asset Divestitures

Charles River Laboratories has raised its 2026 profit forecast following a strategic divestiture of non-core and underperforming assets, ...

February 27, 2026 | Friday | Analysis
Rezon Bio Secures U.S. Food and Drug Administration Approval for Commercial Biosimilar Manufacturing at Warsaw-Duchnice Facility

Rezon Bio announces that its Warsaw-Duchnice facility has received approval from the U.S. Food and Drug Administration (FDA) for the commercial manufactu...

February 20, 2026 | Friday | News
Worldwide Clinical Trials Completes Catalyst Clinical Research Acquisition to Expand Oncology and Global CRO Capabilities

CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value ...

February 18, 2026 | Wednesday | News
FUJIFILM Biotechnologies Opens £400M UK Biomanufacturing Expansion in Teesside

FUJIFILM Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing innovativ...

February 12, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close